Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Trial Comparing the Efficacy and Safety of Insulin Degludec and Insulin Glargine 300 Units/mL in Subjects With Type 2 Diabetes Mellitus Inadequately Treated With Basal Insulin With or Without Oral Antidiabetic Drugs

ClinicalTrials.gov ID: NCT03078478

Open the official record

This page only displays public information reproduced from the official ClinicalTrials.gov record NCT03078478. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 12:56 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This trial is conducted in Europe and North America. The aim of the trial is to compare the efficacy and safety of insulin degludec and insulin glargine 300 units/mL in subjects with type 2 diabetes mellitus inadequately treated with basal insulin with or without oral antidiabetic drugs. Due to change in glycaemic data collection process, this trial is amended to allow for a full 36 weeks (maintenance 2 period) of the use of the new process.

Study identification

NCT ID
NCT03078478
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Novo Nordisk A/S
Industry
Enrollment
1,609 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 13, 2017 (Actual)
Primary completion
Feb 13, 2019 (Actual)
Completion
Mar 4, 2019 (Actual)
Last update posted
Jan 11, 2022

2017 – 2019

United States locations

U.S. sites
156
U.S. states
39
U.S. cities
138
Facility City State ZIP Site status
Novo Nordisk Investigational Site Anniston Alabama 36207 —
Novo Nordisk Investigational Site Birmingham Alabama 35211 —
Novo Nordisk Investigational Site Chandler Arizona 85224 —
Novo Nordisk Investigational Site Fountain Hills Arizona 85268 —
Novo Nordisk Investigational Site Glendale Arizona 85306-4652 —
Novo Nordisk Investigational Site Glendale Arizona 85306 —
Novo Nordisk Investigational Site Glendale Arizona 85308 —
Novo Nordisk Investigational Site Phoenix Arizona 85037 —
Novo Nordisk Investigational Site Tucson Arizona 85741 —
Novo Nordisk Investigational Site Buena Park California 90620 —
Novo Nordisk Investigational Site Concord California 94520 —
Novo Nordisk Investigational Site Downey California 90242 —
Novo Nordisk Investigational Site Duarte California 91010 —
Novo Nordisk Investigational Site Fresno California 93720 —
Novo Nordisk Investigational Site La Jolla California 92037 —
Novo Nordisk Investigational Site Lancaster California 93534 —
Novo Nordisk Investigational Site Lomita California 90717 —
Novo Nordisk Investigational Site Los Alamitos California 90720 —
Novo Nordisk Investigational Site Los Angeles California 90057 —
Novo Nordisk Investigational Site Moreno Valley California 92555 —
Novo Nordisk Investigational Site Northridge California 91325 —
Novo Nordisk Investigational Site Palm Springs California 92262 —
Novo Nordisk Investigational Site Pomona California 91766-2007 —
Novo Nordisk Investigational Site Poway California 92064 —
Novo Nordisk Investigational Site Riverside California 92506 —
Novo Nordisk Investigational Site Roseville California 95661 —
Novo Nordisk Investigational Site Sacramento California 95821 —
Novo Nordisk Investigational Site San Mateo California 94401 —
Novo Nordisk Investigational Site San Ramon California 94583 —
Novo Nordisk Investigational Site Stanford California 94305 —
Novo Nordisk Investigational Site Vista California 92083 —
Novo Nordisk Investigational Site Walnut Creek California 94598 —
Novo Nordisk Investigational Site West Hills California 91304 —
Novo Nordisk Investigational Site Colorado Springs Colorado 80918 —
Novo Nordisk Investigational Site Englewood Colorado 80113 —
Novo Nordisk Investigational Site Waterbury Connecticut 06708 —
Novo Nordisk Investigational Site Bradenton Florida 34201 —
Novo Nordisk Investigational Site Brandon Florida 33511 —
Novo Nordisk Investigational Site Clearwater Florida 33765 —
Novo Nordisk Investigational Site Cooper City Florida 33024 —
Novo Nordisk Investigational Site Jacksonville Florida 32258 —
Novo Nordisk Investigational Site Jacksonville Florida 32277 —
Novo Nordisk Investigational Site Miami Florida 33175 —
Novo Nordisk Investigational Site Miami Springs Florida 33166 —
Novo Nordisk Investigational Site New Port Richey Florida 34652 —
Novo Nordisk Investigational Site Orlando Florida 32825 —
Novo Nordisk Investigational Site Ormond Beach Florida 32174 —
Novo Nordisk Investigational Site Palm Harbor Florida 34684-3609 —
Novo Nordisk Investigational Site Pembroke Pines Florida 33027 —
Novo Nordisk Investigational Site Port Charlotte Florida 33952 —
Novo Nordisk Investigational Site Tampa Florida 33606 —
Novo Nordisk Investigational Site Marietta Georgia 30067 —
Novo Nordisk Investigational Site Roswell Georgia 30076 —
Novo Nordisk Investigational Site Honolulu Hawaii 96814 —
Novo Nordisk Investigational Site Blackfoot Idaho 83221 —
Novo Nordisk Investigational Site Chicago Illinois 60607 —
Novo Nordisk Investigational Site Gurnee Illinois 60031 —
Novo Nordisk Investigational Site Peoria Illinois 61603 —
Novo Nordisk Investigational Site Skokie Illinois 60077 —
Novo Nordisk Investigational Site Springfield Illinois 62711 —
Novo Nordisk Investigational Site Wauconda Illinois 60084 —
Novo Nordisk Investigational Site Evansville Indiana 47713 —
Novo Nordisk Investigational Site Mishawaka Indiana 46544 —
Novo Nordisk Investigational Site Valparaiso Indiana 46383 —
Novo Nordisk Investigational Site Council Bluffs Iowa 51501 —
Novo Nordisk Investigational Site West Des Moines Iowa 50265 —
Novo Nordisk Investigational Site Topeka Kansas 66606 —
Novo Nordisk Investigational Site Lexington Kentucky 40502 —
Novo Nordisk Investigational Site Lexington Kentucky 40503 —
Novo Nordisk Investigational Site Louisville Kentucky 40213 —
Novo Nordisk Investigational Site Paducah Kentucky 42001 —
Novo Nordisk Investigational Site New Orleans Louisiana 70119 —
Novo Nordisk Investigational Site Rockville Maryland 20852 —
Novo Nordisk Investigational Site Bloomfield Hills Michigan 48302 —
Novo Nordisk Investigational Site Richfield Minnesota 55432 —
Novo Nordisk Investigational Site Chesterfield Missouri 63017 —
Novo Nordisk Investigational Site Kalispell Montana 59901 —
Novo Nordisk Investigational Site Elkhorn Nebraska 68022 —
Novo Nordisk Investigational Site Fremont Nebraska 68025 —
Novo Nordisk Investigational Site Omaha Nebraska 68144 —
Novo Nordisk Investigational Site Henderson Nevada 89052 —
Novo Nordisk Investigational Site Las Vegas Nevada 89109 —
Novo Nordisk Investigational Site Las Vegas Nevada 89118 —
Novo Nordisk Investigational Site Las Vegas Nevada 89148 —
Novo Nordisk Investigational Site Nashua New Hampshire 03063 —
Novo Nordisk Investigational Site East Brunswick New Jersey 08816 —
Novo Nordisk Investigational Site Lawrenceville New Jersey 08648 —
Novo Nordisk Investigational Site Albuquerque New Mexico 87102 —
Novo Nordisk Investigational Site Albuquerque New Mexico 87109-2134 —
Novo Nordisk Investigational Site Albany New York 12203 —
Novo Nordisk Investigational Site New Windsor New York 12553 —
Novo Nordisk Investigational Site New York New York 10016 —
Novo Nordisk Investigational Site Northport New York 11768 —
Novo Nordisk Investigational Site West Seneca New York 14224 —
Novo Nordisk Investigational Site Charlotte North Carolina 28210 —
Novo Nordisk Investigational Site Charlotte North Carolina 28277 —
Novo Nordisk Investigational Site Greensboro North Carolina 27408 —
Novo Nordisk Investigational Site Greenville North Carolina 27834 —
Novo Nordisk Investigational Site Greenville North Carolina 27858 —
Novo Nordisk Investigational Site Morehead City North Carolina 28557-4346 —
Novo Nordisk Investigational Site Statesville North Carolina 28625 —
Novo Nordisk Investigational Site Wilmington North Carolina 28401 —
Novo Nordisk Investigational Site Columbus Ohio 43212 —
Novo Nordisk Investigational Site Columbus Ohio 43213 —
Novo Nordisk Investigational Site Maumee Ohio 43537 —
Novo Nordisk Investigational Site Toledo Ohio 43614 —
Novo Nordisk Investigational Site Norman Oklahoma 73069 —
Novo Nordisk Investigational Site Beaver Pennsylvania 15009 —
Novo Nordisk Investigational Site McMurray Pennsylvania 15317 —
Novo Nordisk Investigational Site Philadelphia Pennsylvania 19114 —
Novo Nordisk Investigational Site Anderson South Carolina 29621 —
Novo Nordisk Investigational Site Gaffney South Carolina 29341 —
Novo Nordisk Investigational Site Greenville South Carolina 29615 —
Novo Nordisk Investigational Site Greer South Carolina 29651 —
Novo Nordisk Investigational Site Mt. Pleasant South Carolina 29464 —
Novo Nordisk Investigational Site Pelzer South Carolina 29669 —
Novo Nordisk Investigational Site West Columbia South Carolina 29169 —
Novo Nordisk Investigational Site Dakota Dunes South Dakota 57049 —
Novo Nordisk Investigational Site Bristol Tennessee 37620-7352 —
Novo Nordisk Investigational Site Chattanooga Tennessee 37404 —
Novo Nordisk Investigational Site Chattanooga Tennessee 37411 —
Novo Nordisk Investigational Site Kingsport Tennessee 37660 —
Novo Nordisk Investigational Site Knoxville Tennessee 37909 —
Novo Nordisk Investigational Site Nashville Tennessee 37203 —
Novo Nordisk Investigational Site Nashville Tennessee 37232 —
Novo Nordisk Investigational Site Amarillo Texas 79106 —
Novo Nordisk Investigational Site Arlington Texas 76012-4637 —
Novo Nordisk Investigational Site Austin Texas 78731 —
Novo Nordisk Investigational Site Dallas Texas 75226 —
Novo Nordisk Investigational Site Dallas Texas 75390-9302 —
Novo Nordisk Investigational Site Fort Worth Texas 76132 —
Novo Nordisk Investigational Site Houston Texas 77024 —
Novo Nordisk Investigational Site Houston Texas 77066 —
Novo Nordisk Investigational Site Humble Texas 77338 —
Novo Nordisk Investigational Site Kerrville Texas 78028 —
Novo Nordisk Investigational Site New Braunfels Texas 78130 —
Novo Nordisk Investigational Site Plano Texas 75075 —
Novo Nordisk Investigational Site San Antonio Texas 78215 —
Novo Nordisk Investigational Site San Antonio Texas 78224 —
Novo Nordisk Investigational Site San Antonio Texas 78228-6205 —
Novo Nordisk Investigational Site San Antonio Texas 78229 —
Novo Nordisk Investigational Site San Antonio Texas 78249 —
Novo Nordisk Investigational Site Waco Texas 76710 —
Novo Nordisk Investigational Site Bountiful Utah 84010 —
Novo Nordisk Investigational Site Murray Utah 84123 —
Novo Nordisk Investigational Site Ogden Utah 84405 —
Novo Nordisk Investigational Site Bennington Vermont 05201 —
Novo Nordisk Investigational Site Chesapeake Virginia 23321 —
Novo Nordisk Investigational Site Midlothian Virginia 23114 —
Novo Nordisk Investigational Site Norfolk Virginia 23510-2015 —
Novo Nordisk Investigational Site Richmond Virginia 23219 —
Novo Nordisk Investigational Site Virginia Beach Virginia 23454 —
Novo Nordisk Investigational Site Olympia Washington 98502 —
Novo Nordisk Investigational Site Spokane Washington 99201 —
Novo Nordisk Investigational Site Kenosha Wisconsin 53144 —
Novo Nordisk Investigational Site West Allis Wisconsin 53227 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 73 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03078478, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 11, 2022 · Synced Nov 15, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.